Canada Pension Plan Investment Board’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$440K Sell
5,400
-45,106
-89% -$3.26M ﹤0.01% 1316
2026
Q1
$3.44M Sell
50,506
-24,894
-33% -$1.76M ﹤0.01% 823
2025
Q4
$5.73M Buy
+75,400
New +$5.48M ﹤0.01% 753
2025
Q3
Sell
-211,000
Closed -$10.3M 1456
2025
Q2
$10.3M Buy
211,000
+48,700
+30% +$2.31M 0.01% 587
2025
Q1
$8.27M Buy
162,300
+138,800
+591% +$6.93M 0.01% 607
2024
Q4
$1.06M Buy
+23,500
New +$1.01M ﹤0.01% 1009
2023
Q1
Sell
-28,300
Closed -$1.08M 1181
2022
Q4
$1.08M Sell
28,300
-5,200
-16% -$216K ﹤0.01% 843
2022
Q3
$1.68M Buy
+33,500
New +$1.64M ﹤0.01% 758
2021
Q1
Sell
-222,200
Closed -$13.6M 1486
2020
Q4
$13.6M Buy
+222,200
New +$13.1M 0.02% 431
2020
Q1
Sell
-56,183
Closed -$2.7M 1439
2019
Q4
$2.7M Buy
+56,183
New +$2.39M 0.01% 779
2019
Q2
Sell
-459
Closed -$17K 1425
2019
Q1
$17K Buy
+459
New +$15.4K ﹤0.01% 1389
2017
Q4
Sell
-23,200
Closed -$464K 1215
2017
Q3
$464K Sell
23,200
-17,400
-43% -$341K ﹤0.01% 996
2017
Q2
$744K Hold
40,600
﹤0.01% 959
2017
Q1
$400K Buy
40,600
+25,700
+172% +$311K ﹤0.01% 998
2016
Q4
$163K Buy
14,900
+4,900
+49% +$51.4K ﹤0.01% 961
2016
Q3
$140K Buy
+10,000
New +$81.3K ﹤0.01% 994
2015
Q4
Sell
-15,800
Closed -$422K 1259
2015
Q3
$422K Buy
+15,800
New +$676K ﹤0.01% 964

Other funds holding PTCT

Canada Pension Plan Investment Board's PTCT Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its PTC Therapeutics (PTCT) stake by 89% in Q2 2026, selling an estimated $3.26M and leaving 5,400 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

Canada Pension Plan Investment Board first reported a position in PTCT in Q3 2015 and has held it in 17 quarters since. The position peaked at $13.6M in Q4 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Canada Pension Plan Investment Board held 5,400 shares of PTC Therapeutics worth $440K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 45,106 PTC Therapeutics shares in Q2 2026, an estimated $3.26M.
  • PTC Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1316 holding.
  • Canada Pension Plan Investment Board first reported a position in PTC Therapeutics in Q3 2015 and has held it in 17 quarters since.
  • Canada Pension Plan Investment Board's PTC Therapeutics position peaked at $13.6M in Q4 2020.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.